Best Addiction and Substance Abuse Grants in Oregon

Oregon 501(c)(3) nonprofits providing direct mental health counseling, addiction treatment, crisis intervention, or after-school mentorship can seek up to US $25,000 in program support. Focused on direct services, the Reser Family Foundation’s Next Gen Council favors established organizations that track outcomes, serve broad community needs, and collaborate with other funded partners.

About CommonSpirit

A calling that defines and unites

At CommonSpirit Health, we passionately care for the most vulnerable, relentlessly innovate how and where healing can happen and believe in uniting to benefit the common good. Our expansive network spans diverse communities, uniquely positioning us to meet their changing needs, improve population health and help chart the path to health equity.

Our mission, vision and values inform every aspect of our work each day and remind us that we serve our patients, their families, our communities – and each other. Our community health, research and home health programs help us address the primary barriers to healthier communities.

Sponsorship requests

We’re proud to support nonprofits that expand access to care, advance health equity and healthier communities. Learn more about our priorities.

Supporting our communities

CommonSpirit Health and our local facilities support nonprofit organizations that share our mission, vision and values. We give priority to programs that improve access to care and promote health equity and healthier communities.

CommonSpirit is proud to support nonprofit organizations that help improve the health and well-being of our communities. Guided by our mission, vision and values, we prioritize projects that focus on advancing health equity, improving access to care and improving community wellness.

Oregon 501(c)(3) nonprofits, including those addressing addiction and substance use disorders, can access funding for community-focused programs through the Harold & Arlene Schnitzer Care Foundation’s CommuniCare initiative. The program offers US $1,000 - US $15,000, with student-led “mini-foundations” selecting Oregon organizations whose work matches their annually defined mission priorities.

Oregon 501(c)(3) nonprofits, tribes, and local governments working on addiction, problem gambling, health, or related community programs can seek project funding. Focused on community well-being, Three Rivers Foundation invites applications for innovative, collaborative efforts that benefit Coos, Lane, Douglas, Curry, and Lincoln counties, Native American communities in Oregon, or projects with a statewide impact.

Oregon 501(c)(3) nonprofits addressing substance abuse or human trafficking can seek $5,000 - $50,000 to provide treatment, support services, and prevention programs. Focused on freeing people from addiction and exploitation, Slave 2 Nothing Foundation invites eligible service providers in states with In-N-Out Burger locations, including Oregon, to request an invitation to apply.

Nonprofit 501(c)(3) organizations in Oregon with budgets under $10M can seek funding to initiate or expand programs addressing substance abuse, mental health, housing, food insecurity, domestic violence, and at-risk youth. Charis Fund supports social welfare, health, and education projects with grants of US $2,500 - US $7,500 for local, community-based services.

Grants support research organizations testing SBIRT/P approaches for alcohol, tobacco, and other drug use and misuse among adults experiencing health disparities in Oregon and nationwide. Grants from the National Institutes of Health help addiction and substance use disorder programs partner with healthcare and community organizations to prospectively evaluate screening, brief intervention, and referral to treatment or prevention models.

Oregon charitable organizations and local governments working on addiction and substance use disorders, alcoholism, or drug use disorder can seek funding that supports education, health, public safety, housing, arts, environment, and related services. Focused on broad community benefit, the Confederated Tribes of Siletz Indians also fund Native American organizations nationwide addressing these and other charitable purposes.

Oregon research institutions and healthcare-affiliated organizations working on adult substance use and health disparities can access funding through the National Institutes of Health to study SBIRT/P approaches for alcohol, tobacco, and other drugs. Projects must prospectively test screening, brief intervention, and referral to treatment or prevention in collaboration with healthcare and community partners; deadlines run through 2027.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

The HEAL Initiative's Career Development Awards aim to empower early career researchers and clinicians in implementation science. By providing training and funding, this initiative seeks to address substance use prevention and treatment through research projects that align with the HHS Overdose Prevention Strategy. Focused on vital areas such as opioid prescribing, OUD treatment, and recovery support, the program aspires to cultivate a new generation of experts who will significantly impact addiction clinical practices and mentorship.

The Drug-Free Communities (DFC) Support Program aims to foster collaboration among community coalitions to combat youth substance use. Established by the Drug-Free Communities Act of 1997, it encourages partnerships among various stakeholders, including governmental and non-profit agencies. The program focuses on reducing substance use among youth and promoting protective factors within communities. This funding opportunity is available for those who have completed the initial funding cycle or experienced funding interruptions, supporting their ongoing efforts to create a healthier environment for youth.

Small business concerns developing FDA-regulated pharmacotherapies or medical/diagnostic devices for opioid or stimulant use disorders can seek up to US $2,500,000, including work benefiting Oregon. With a mission to advance medical solutions, the National Institutes of Health provides STTR funding to commercialize novel, evidence-based products addressing addiction and substance use disorders.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

The NCDDG program supports innovative research aiming to discover and develop new treatments for mental disorders, including substance use and alcohol use disorders. This initiative encourages collaborations between academic and industry partners to advance neurostimulation techniques and drug/device development. Applicants are invited to submit proposals that focus on specific projects utilizing the U01 mechanism, with a clear emphasis on rationally designed candidate agents and cutting-edge technologies. Letters of Intent are encouraged 30 days prior to the submission deadline.

Organizations providing research education experiences in substance use and addiction can apply for NIH funding of up to US $1,250,000, including those based in Oregon. Focused on skills-development courses and hands-on research experiences, the National Institutes of Health supports programs that help build a more diverse biomedical and behavioral science workforce.

Clinician-scientist training programs at eligible institutions in Oregon and other U.S. locations can access funding to provide intensive mentored research careers in substance use and substance use disorder. Grants from US Dept. of Health & Human Services: National Institutes of Health support K12 programs with up to US $750,000 for supervised research and career development.

Research institutions and teams conducting high-priority HIV and substance use studies, including work on addiction and drug use disorders, can apply for funding up to US $1,500,000 from the National Institutes of Health. Focused on innovative projects from basic to clinical and implementation science, this opportunity may benefit Oregon-based addiction and substance abuse researchers.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

The NIDA Research Education Program (R25) aims to enhance the training of a workforce skilled in biomedical, behavioral, and clinical research, particularly regarding substance use disorders. This program supports educational activities that prepare clinicians and clinical researchers. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline. This initiative does not fund non-research-related clinical training.

Oregon research institutions and clinical trial teams focused on addiction and substance use disorders can access funding through the US Department of Health & Human Services: Food and Drug Administration for projects in analgesics, anesthetics, and addiction medicine. Awards of US $2,000,000 support clinical trials, outcome measures, and evidence-based plans to improve prescribing for pain and substance use disorders across the U.S.

The Tobacco, Alcohol, and Cannabis Policy Research for Health Equity grant aims to support research on policies affecting tobacco, alcohol, and cannabis use in the U.S. This initiative focuses on how these policies impact populations facing health disparities. Key components include engaging community organizations to advance equity in cancer prevention. Important deadlines for applications range from February 2025 to October 2027, providing opportunities for both standard and renewal submissions.

The Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional) aims to fund projects that explore policies related to tobacco, alcohol, and cannabis in the U.S. The focus is on understanding how these policies affect usage and exposure among disadvantaged populations. Engaging community organizations is essential for promoting equity in cancer prevention. This initiative is crucial for advancing health equity and reducing disparities in substance use.

The Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional) invites applications that address urgent research needs in substance use epidemiology and health services. This funding opportunity encourages pilot studies focusing on emerging drug issues, unexpected prescription drug abuse trends, and timely medical system challenges. Letters of Intent are recommended 30 days before the proposal deadline, emphasizing the necessity for rapid review and funding to address pressing scientific questions.

The National Institute on Drug Abuse (NIDA) is launching a specialized entrepreneurship program aimed at life science researchers in the field of substance use disorders (SUD). This initiative will equip researchers with essential skills to transform their innovative ideas into viable products, focusing on aspects such as market evaluation, customer discovery, and intellectual property. The course will be delivered in a hybrid format to engage US-based SUD researchers effectively, fostering collaboration and advancing the field.